Joseph C Scodari insider trades

Open-market stock purchases and sales by Joseph C Scodari, Director at Acurx Pharmaceuticals, Inc, from SEC Form 4 filings since Dec 31, 2009.

Track record: 100% of 6 scored buys are up 5% or more since purchase, averaging +79%.

Recent trades

DateStockTradeValue
Apr 20, 2026ACXP Acurx Pharmaceuticals, IncBought (not open market)—

Companies traded

  • ACXP Acurx Pharmaceuticals, Inc: 1 buy, last Apr 20, 2026
  • OPTN OptiNose, Inc: 6 buys, last Jun 8, 2022
  • CVD Covance Inc: 2 buys, last Feb 19, 2015
  • ENDP Endo Health Solutions Inc: other filings, last Mar 12, 2013

Get free alerts when Joseph C Scodari files a new trade →